Crossmark

In vivo and in situ programming of tumor immunity by combining oncolytics and PD-1 immune checkpoint blockade

Published Online: 2017-05-24

Published Print: 2017-12

Authors

Bartee, Eric

Li, Zihai
Funding

Funding for this research was provided by:

National Institutes of Health (R01CA194090, R21AI123803, R01CA213290)

american cancer society (RSG-17-047-01-MPC)
License Information

Text and Data Mining valid from 2017-05-24

Version of Record valid from 2017-05-24
More Information

Article History

Received: 24 April 2017

Accepted: 11 May 2017

First Online: 24 May 2017

Document is current